Featured OTC Stock
ImmunoCellular (OTC-BB: IMUC) Could Be the Next Dendreon
Dendreon Corporation’s (DNDN) eye-popping 1,000% rise after the approval of its Provenge drug for the treatment of prostate cancer may be getting a lot of press now, but some savvy investors are turning their attention towards smaller players that could be the next big gain. But while some smaller OTC-BB cancer treatment companies, like Genta [...][...] Read MoreOTC Market News
Neonode Signs zForce License Agreement with Daesung Electric
Neonode, Inc. (OTC-BB: NEON), an optic touchscreen technology company focus[...]- Ingen Technologies Receives “Green Light” to Target U.S. Military With Innovative Patented Medical Product Line
- EcoloCap Solutions (OTC-BB: ECOS) Announces EPA Testing on M-Fuel
- Regenicin (OTC-BB: WDSTD) Appoints Amgen Co-Founder to Board of Directors
- Regenicin (OTC-BB: WDSTD) Completes Acquisition of Worldwide Exclusive Know-How Technology License from Lonza Walkersville
- Ingen Technologies, Inc. Products Fill Key Void for Medical Distributor
Penny Stock Highlights